在塞特拉林和安慰剂下情绪改善的常见症状几何学与明显的神经模式相关
Lucie Berkovitch1,2,3,4,5,6, Kangjoo Lee1,2, Jie Ji7
1Department of Psychiatry, Neuroscience, and Psychology, https://ror.org/03v76x132Yale University School of Medicine, New Haven, CT, USA.
Psychological medicine
|July 4, 2025
概括
研究人员确定了主要抑郁症 (MDD) 症状改善的常见模式,这种模式在塞特拉林和安慰剂治疗之间有所不同. 基线大脑连接预测了塞特拉林的改善,这表明了个性化治疗的潜力.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于对改善机制的不完全理解,重大抑郁症 (MDD) 治疗个性化仍然具有挑战性.
- 确定抗抑郁药反应的可靠预测因素对于定制治疗至关重要.
研究的目的:
- 为了确定MDD临床改善的数据驱动模式.
- 根据抗抑郁药治疗反应量化神经与症状的关系.
- 探索基线临床和神经因素如何预测治疗结果.
主要方法:
- 对EMBARC数据集的二次分析,涉及使用塞特拉林或安慰剂治疗的MDD参与者.
- 抑郁,焦虑,自杀和躁狂症状的主要组件分析 (PC) 定义临床改善措施 (PC1).
- 线性建模以评估基线全球大脑连接 (GBC) 和PC1分数之间的关系.
主要成果:
- 在治疗组中观察到症状改善 (PC1) 的共同模式,但PC1评分因治疗而有显著差异.
- 塞特拉林治疗显示出基线GBC和症状改善 (PC1) 之间的相关性,与安慰剂组不同.
- 确定了一种共同的症状改善特征,在塞特拉林和安慰剂之间有明显的响应强度.
结论:
- 在神经回路上映的数据驱动的症状概况揭示了独特的治疗反应神经特征.
- 这些发现可能有助于为未来的临床试验和个性化MDD治疗策略选择最佳患者.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
373
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
373
The Placebo Effect
6.3K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.3K
Depressive Disorders: MDD and Dysthymia
224
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
224
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
609
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
609
Antidepressant Drugs: Overview
786
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
786
Depressive Disorders: Etiology
173
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
173


